Keppra 1000 mg

Страна: Йордания

Език: английски

Източник: JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

Изтегляне Листовка (PIL)
07-12-2023

Активна съставка:

Levetiracetam 1000 mg

Предлага се от:

مستودع أدوية سليمان طنوس وأولاده - Suleiman Tannous & Sons Co. Ltd

АТС код:

N03AX14

INN (Международно Name):

Levetiracetam 1000 mg

дозиране:

1000 mg

Броя в опаковка:

100

Произведено от:

يوسي بي فارما (بلجيكا)

Каталог на резюме:

97.6 :سعر الجمهور + الضريبة

Листовка

                                HARMONY
_Packaging artwork and technical drawings _
_Approval Information_
Page 1 of 3
PROJECT:
CO-0042959
DOCUMENT:
PPC-0027412.pdf
DOCUMENT DESCRIPTION:
VERSION:
3
VERSION ID:
00002_0001104088
DOWNLOADED:
Sep 8, 2021 at 10:04 AM GMT+04:00
BY:
Lakkis, Fadilla (FML41544)
APPROVAL STATE:
DRAFT
PATIENT LEAFLET
250 MG; 500 MG;
1000 MG FILM-COATED TABLETS
Read all of this leaflet carefully before you start taking
this medicine.
−
Keep this leaflet. You may need to read it again.
−
If you have any questions, ask your doctor or pharmacist.
−
This medicine has been prescribed for you personally
or your child.
Don’t pass it on to other people - it may harm them even
if their symptoms seem to be the same as yours.
−
If any of the side effects gets serious, or if you notice
any side effects not listed in this leaflet, please tell your
doctor or pharmacist.
IN THIS LEAFLET
1.
WHAT KEPPRA IS AND WHAT IT IS USED FOR
2.
BEFORE YOU TAKE KEPPRA
3.
HOW TO TAKE KEPPRA
4.
POSSIBLE SIDE EFFECTS
5.
HOW TO STORE KEPPRA
6. FURTHER INFORMATION
1.
WHAT KEPPRA IS AND WHAT IT IS USED FOR
Keppra contains the active ingredient levetiracetam. It
belongs to antiepileptic medicines, which are used to treat
fits (
seizures
) in epilepsy.
On its own, Keppra is used to treat:
•
partial onset seizure with or without secondary
generalisation (the epilepsy form in which the fits
initially affect only one side of the brain, but could
thereafter extend to larger areas on both sides of the
brain) - in adults and adolescents from 16 years of age
with newly diagnosed epilepsy
As an add-on to other antiepileptic medicines, Keppra is
used to treat:
•
partial onset seizures with or without generalisation in
adults, adolescents, children and infants from one
month of age with epilepsy
•
myoclonic seizures (short, shock-like jerks of a muscle
or group of muscles) in adults and adolescents from
12 years of age with juvenile myoclonic epilepsy
•
primary generalised tonic-clonic seizures (major fits,
including loss of consciousness) in adults an
                                
                                Прочетете целия документ
                                
                            

Сигнали за търсене, свързани с този продукт

Преглед на историята на документите